Strikingly, liver specific ChREBP deficiency was however able to significantly delay HCC burden, with only scattered liver preneoplastic lesions being detected in response to the activation these oncogenes or inhibiton of these tumor suppressors (Fig. 9c, d). Here, MLXIPL is linked to neoplasm.